Publication | Closed Access

Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies

Neurodegenerative DiseasesAlzheimer's DiseaseMedicinePotential Multifunctional Anti-alzheimerNeuropharmacologyPharmacological AgentPharmacotherapyNeurologyNeuroprotectionNovel Donepezil-chalcone-rivastigmine HybridsDrug DevelopmentPharmacologySilico StudiesNovel TherapyDrug Discovery